Pacritinib Versus Best Available Therapy to Treat Myelofibrosis

Clinical trial NCT01773187 · TERMINATED

Trial details

NCT number: NCT01773187
Sponsor: CTI BioPharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis

Start date: 2013-01-01
Primary completion: 2015-01-01
Enrollment: 327

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.